Yoann Bonnamour

Yoann Bonnamour is an experienced finance professional currently serving as a Director at Merieux Equity Partners since January 2020. In addition, Bonnamour holds various board director positions at CorFlow, Prothea Technologies, Broken String Biosciences, CAIRDAC, SeqOne Genomics, and Cell-Easy. Bonnamour is also a member of the Strategic Committee at OMX Ventures. Previous experience includes a role as a Board Member at IMACTIS, which was sold to GE Healthcare, and as a Healthcare Investment Manager at M Capital Partners, a private equity firm managing over €500 million in investments. Educational qualifications include a Master’s degree in Banking, Corporate, Finance, and Securities Law from emlyon business school and studies at the University of Montpellier.